IMS Health CEO Awarded $23.5 Million in Shares, Topping PeersBy and
Executive gets outsized stock grant for second year running
Bousbib earns more than total pay for Pfizer, Lilly chiefs
IMS Health Holdings Inc., which tracks medical prescriptions and sells the data, paid its chief executive officer a $23.5 million stock award, more than the entire pay packages for the heads of much larger drug companies such as Pfizer Inc. and Eli Lilly & Co.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.